Navega Therapeutics
Marcus is a Professor at the New York University School of Medicine. His labs have focused on the development of novel tools to understand and engineer protein-DNA interactions. He has specifically concentrated on the development of zinc finger domains.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Navega Therapeutics
Navega Therapeutics has developed a patented, non-permanent gene therapy to target pain that is non-addictive, highly specific, and long-lasting. Navega Therapeutics has imitated this process by utilizing a novel gene therapy to target pain in a non-permanent way.